ArticleMaterials today. Bio2026
Melt-electrowriting fibrous scaffolds modified with nano-topography structures promoting cardiomyocytes synergistic contraction.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melt-electrowriting (MEW) is an emerging strategy to fabricate microfibrous scaffolds that mimic the functional collagen fibers present in the native extracellular matrix (ECM). However, the main challenge remains in producing the nanoscale features that are widely found in ECM. In this work, MEW polycaprolactone (PCL) fibrous scaffolds with nano-topography structures (NS) were prepared to promote cell growth. Parallel PCL fibers were coated with NS by self-induced crystallization, which enhanced the adhesion and spreading of H9C2 cells. Compared with pristine scaffolds, the NS scaffolds exhibited improved hydrophilicity with a lower water contact angle of ∼50.70°. NS scaffolds exhibited abundant nano sites, which are beneficial for the cell-scaffold interaction and for achieving living constructs at a high cell density. Furthermore, NS scaffolds promoted cell-cell interactions and synergistic contraction of neonatal mouse cardiomyocytes (CMs). Dendritic pseudopods enabled CMs to spread along preferentially parallel to the direction of the lamellar. RNA sequencing analyses further revealed that the NS scaffolds upregulate cell cycle regulation-related pathways, cell communication-related pathways, calcium regulation-related pathways, cell motility-related pathways, and cellular adhesion and spreading-related pathways. It is envisioned that the proposed NS scaffolds may serve as promising candidates for tissue regeneration and biomedical engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.